COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center


Purpose of Study

To determine the safety and efficacy of CardiAMP cell therapy system in patients with post myocardial infarction heart failure

Trial Status


Eligibility Criteria

Older than 21 years of age, NYHA Class II or III, chronic ischemic left ventricular dysfunction, previous MI

Duration of Participation

Approximately two years

Contact Name: Ali McCombs, RN

Contact Phone: 515-235-5106

Contact Email: